Literature DB >> 17618615

Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors.

N Koubaa1, A Nakbi, M Smaoui, N Abid, R Chaaba, M Abid, M Hammami.   

Abstract

INTRODUCTION: Total plasma homocysteine (tHcy) is an emerging risk factor for the development of atherosclerosis. However, its relationship with diabetes is still unclear.
OBJECTIVES: We evaluated the association between tHcy levels and methylenetetrahydrofolate reductase (MTHFR) 677C-->T genotype in a type 2 diabetes mellitus (DM) population and their relationship with oxidized LDL (ox-LDL) according to dietary habits and vascular complications. DESIGN AND METHODS: Eighty-six DM patients were compared to 120 healthy volunteers.
RESULTS: Associated higher tHcy levels and significantly higher ox-LDL levels (p<0.001) were found in DM patients compared to healthy subjects. Homozygosity for the T allele of MTHFR was more frequent in diabetics than in healthy subjects (12.8% vs. 7.2%) and it was associated with higher tHcy levels. Moreover, this elevated level was associated with significantly higher ox-LDL levels in DM patients with hypertension (p<0.05). Improving folate and vitamin C intakes could have beneficial effects on lowering the tHcy and ox-LDL levels.
CONCLUSIONS: The interplay of genetic and dietary factors modulates the effect of homocysteine on cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618615     DOI: 10.1016/j.clinbiochem.2007.05.017

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Periodontal treatment decreases plasma oxidized LDL level and oxidative stress.

Authors:  Naofumi Tamaki; Takaaki Tomofuji; Daisuke Ekuni; Reiko Yamanaka; Manabu Morita
Journal:  Clin Oral Investig       Date:  2010-08-18       Impact factor: 3.573

2.  Association of methylenetetrahydrofolate reductase C677T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.

Authors:  Lin Zhang; Rui-Xing Yin; Wan-Ying Liu; Lin Miao; Dong-Feng Wu; Lynn Htet Htet Aung; Xi-Jiang Hu; Xiao-Li Cao; Jin-Zhen Wu; Shang-Ling Pan
Journal:  Lipids Health Dis       Date:  2010-10-27       Impact factor: 3.876

3.  Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine.

Authors:  Elena C Gross; Niveditha Putananickal; Anna-Lena Orsini; Deborah R Vogt; Peter S Sandor; Jean Schoenen; Dirk Fischer
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

4.  Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults.

Authors:  Liyuan Zhou; Jia Liu; Yu An; Ying Wang; Guang Wang
Journal:  Front Cardiovasc Med       Date:  2022-06-13

5.  Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.

Authors:  N Alexandru; I Jardín; D Popov; M Simionescu; J García-Estañ; G M Salido; J A Rosado
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

6.  Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients.

Authors:  Tarek Mk Motawi; Mohamed A Abou-Seif; Ahmed Ma Bader; Mohamed O Mahmoud
Journal:  BMC Endocr Disord       Date:  2013-08-21       Impact factor: 2.763

7.  Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.

Authors:  N Alexandru; I Jardín; D Popov; M Simionescu; J García-Estañ; G M Salido; J A Rosado
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

8.  Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach.

Authors:  Tao Huang; JingJing Ren; Jinyan Huang; Duo Li
Journal:  BMC Genomics       Date:  2013-12-10       Impact factor: 3.969

9.  Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients.

Authors:  Mai A Abd-Elmawla; Sherine M Rizk; Ilham Youssry; Amira A Shaheen
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.